TEGNA INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TEGNA INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.90B | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $2.00B | Mar 1, 2018 |
| FY2017 | Dec 31, 2015 | $1.76B | Mar 1, 2018 |
| FY2016 | Dec 28, 2014 | $2.63B | Feb 28, 2017 |
| FY2015 | Dec 29, 2013 | $1.60B | Feb 29, 2016 |
| FY2014 | Dec 30, 2012 | $5.35B | Feb 25, 2015 |
| FY2013 | Dec 25, 2011 | $5.24B | Feb 27, 2014 |
| FY2012 | Dec 26, 2010 | $5.44B | Feb 26, 2013 |
| FY2011 | Dec 27, 2009 | $5.51B | Feb 22, 2012 |
| FY2010 | Dec 28, 2008 | $6.64B | Feb 23, 2011 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.71B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $3.10B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $2.91B | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $3.28B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.99B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $2.94B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $2.30B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $2.21B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.90B | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $2.00B | Mar 1, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $219.86M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $599.82M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $476.72M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $630.47M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $476.96M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $482.78M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $286.24M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $405.67M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $273.74M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $436.70M | Mar 1, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $442.97M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $784.78M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $733.55M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $990.63M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $802.22M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $870.98M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $559.02M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $698.48M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $545.90M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $708.15M | Mar 1, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $379.72M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $394.59M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $412.00M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $414.53M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $396.45M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $365.60M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $326.80M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $315.32M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $287.40M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $331.03M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $326.00M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $684.97M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $587.25M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $812.15M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $501.61M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $805.14M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $297.47M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $527.21M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $389.43M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $678.70M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.43M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $52.44M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $54.69M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $51.33M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $63.08M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $45.50M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $88.36M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $65.23M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $76.89M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $94.80M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.87B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $7.33B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $7.00B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $7.33B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $6.92B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $6.85B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $6.95B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $5.28B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $4.96B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $8.54B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.72B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $4.30B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $4.28B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $4.24B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $4.38B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $4.78B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $5.36B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $3.94B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $3.97B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $5.94B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.16B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $3.00B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $2.70B | Mar 2, 2026 |
| FY2025 | Dec 31, 2022 | $3.07B | Mar 2, 2026 |
| FY2024 | Dec 31, 2021 | $2.52B | Feb 27, 2025 |
| FY2023 | Dec 31, 2020 | $2.06B | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $1.59B | Feb 27, 2023 |
| FY2017 | Dec 31, 2017 | $995.04M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $2.27B | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $2.19B | Feb 28, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.02B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $3.02B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $2.98B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.98B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.98B | Feb 27, 2023 |
| FY2022 | Dec 31, 2020 | $2.97B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $2.95B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $2.60B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $2.58B | Mar 2, 2020 |
| FY2017 | Dec 31, 2016 | $2.58B | Mar 1, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.17B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $8.55B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $8.09B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $7.90B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $7.46B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $7.08B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $6.66B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $6.43B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $6.06B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $7.38B | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $291.24M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $693.21M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $361.04M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $551.68M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $56.99M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $40.97M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $29.40M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $135.86M | Mar 2, 2020 |
| FY2019 | Dec 31, 2017 | $98.80M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $15.88M | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.53B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $3.08B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $3.07B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $3.07B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $3.23B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $3.55B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $4.18B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $2.94B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $3.01B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $4.04B | Mar 1, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | 2 | Mar 1, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Mar 1, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 161.10M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 159.90M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 179.90M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 223.40M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 221.40M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | 219.50M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 217.50M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 215.80M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 214.90M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 214.50M | Mar 1, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.46M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $81.36M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $83.53M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $84.76M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $78.47M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $76.47M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $60.62M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $60.29M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $90.17M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $121.64M | Mar 1, 2019 |